| mRNA |
CIL41 |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
0.0004 |
| mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.0004 |
| mRNA |
BRD-K03536150 |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0007 |
| mRNA |
CIL70 |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.003 |
| mRNA |
piperlongumine:MST-312 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.003 |
| mRNA |
MST-312 |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.004 |
| mRNA |
ABT-263 |
CTRPv2 |
pan-cancer |
AAC |
-0.089 |
0.01 |
| mRNA |
CIL56 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.01 |
| mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.078 |
0.01 |
| mRNA |
BRD-K27986637 |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
0.01 |